Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
108.85
+0.96 (+0.89%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna Inc
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
99
100
Next >
Novavax Shares Jumped in January While Others Slipped
February 01, 2023
Updated FDA Covid vaccine policy could've boosted NVAX shares at the end of January, when other pharma stocks slipped, but it may not affect the bottom line.
Via
MarketBeat
Exposures
COVID-19
Product Safety
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell
February 01, 2023
Novavax shares sank 93% last year.
Via
The Motley Fool
This Discount Growth Stock Is a Once-in-a-Decade Buying Opportunity Right Now
January 31, 2023
Moderna stock has dropped 60% from its peak.
Via
The Motley Fool
Why BioNTech And Moderna Shares Are Falling After Pfizer News
January 31, 2023
BioNTech SE - ADR (NASDAQ: BNTX) and Moderna Inc (NASDAQ: MRNA) shares are trading lower Tuesday morning in sympathy with Pfizer Inc. (NYSE:
Via
Benzinga
Biden Administration Plans To End COVID-19 Public Health Emergency In May
January 31, 2023
Via
Benzinga
Could This RSV News Make Moderna a Hot Buy Again?
January 25, 2023
The company could soon have a new vaccine bringing in revenue.
Via
The Motley Fool
What 10 Analyst Ratings Have To Say About Moderna
January 24, 2023
Via
Benzinga
Here's the Worst Mistake Novavax Investors Can Make in 2023
January 20, 2023
Can Novavax still win over the long term?
Via
The Motley Fool
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
January 30, 2023
The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020. Since then, the virus has caused more than 6.8 million deaths.
Via
Benzinga
The RSV Vaccine Battle Wages On With Moderna Scoring A Win Vs. Pfizer, GSK
January 30, 2023
But Moderna stock didn't move higher on the announcement.
Via
Investor's Business Daily
Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate
January 30, 2023
Via
ACCESSWIRE
2 Struggling Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
January 29, 2023
Two of these stocks have what it takes to rebound and deliver lasting gains.
Via
The Motley Fool
Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip
January 27, 2023
The FDA's experts voted in favor of annual boosters on Thursday.
Via
Investor's Business Daily
The 3 Best Biotech Stocks Under $1 to Buy for January
January 26, 2023
Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich.
Via
InvestorPlace
2 Top Biotech Stocks to Buy for the Long Haul
January 26, 2023
Developing new products will be key to the success of both of these biotech leaders.
Via
The Motley Fool
Mergers and Acquisitions in 2023 Off To A Strong Start
January 26, 2023
Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road.
Via
MarketBeat
Exposures
Product Safety
How Could GSK's RSV Vaccine Change its Valuation?
January 26, 2023
GSK's RSV vaccine could be a good earner for the company, according to outside analysts and its own predictions for the future.
Via
MarketBeat
Exposures
Product Safety
Thursday Predictions: 3 Hot Stocks for Tomorrow
January 25, 2023
Airline stocks, credit card stocks, and vaccine stocks are our focus when it comes to the hot stocks for tomorrow. Here's why.
Via
InvestorPlace
Healthcare Sector Is Lagging As We Enter 2022 Earnings Season
January 23, 2023
The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength.
Via
Talk Markets
Moderna, Kellogg And 2 Other Stocks Insiders Are Selling
January 23, 2023
The Nasdaq settled higher on Friday, also notching gains for the week. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
COVID, Shmovid: This Could Be the Next Big Growth Story for Moderna Stock
January 21, 2023
Moderna could follow closely behind Pfizer and GSK in entering the lucrative RSV vaccine market.
Via
The Motley Fool
Stock Market Rally Pulls Back; Microsoft, Google Slash Jobs; Netflix, Goldman, Tesla In Focus: Weekly Review
January 20, 2023
Microsoft and Google are slashing jobs. Netflix and Tesla jumped.
Via
Investor's Business Daily
2 Nasdaq 100 Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
January 20, 2023
The growth-driven Nasdaq 100 is home to two incredible deals in the new year, as well as one previous highflier that can be actively avoided.
Via
The Motley Fool
Pharmaceutical Stocks Pfizer, GSK, Moderna Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market
January 19, 2023
After years of lab failures, the companies could crack open a multibillion-dollar market.
Via
Investor's Business Daily
Moderna and Pfizer Race to Release RSV Vaccines
January 19, 2023
Two of the largest vaccine producers have engaged in the rapid development of RSV vaccines, here's how the companies are tracking so far.
Via
MarketBeat
Exposures
Product Safety
Volatility In Markets Increases, Dow Tumbles Over 600 Points
January 19, 2023
The S&P 500 fell more than 1.5% on Wednesday, recording biggest daily decline in more than one month following weak economic data. US economic reports released Wednesday showed retail sales and...
Via
Benzinga
Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 18, 2023
Gainers Ontrak, Inc. (NASDAQ: OTRK) shares jumped 101.7% to $1.1599 after the company announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+...
Via
Benzinga
Why Is Zomedica (ZOM) Stock Up Today?
January 18, 2023
Zomedica (ZOM) stock is on the rise Wednesday after the company signed a strategic restructuring agreement with Qorvo Biotechnologies.
Via
InvestorPlace
Moderna (MRNA) Stock Pops on RSV Vaccine Trial Results
January 18, 2023
Moderna (MRNA) stock is on the move Wednesday alongside positive results from its latest Phase 3 mRNA-1345 vaccine trial.
Via
InvestorPlace
Moderna Gets Good News, but Another Biotech Stock Is Falling Again
January 18, 2023
The Nasdaq looked poised for modest gains once again on Wednesday.
Via
The Motley Fool
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.